British Journal of Cancer - Table of Contents alert Volume 114 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 12 (1305-1426) Published online 14 June 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Index Errata Corrigenda Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top Hallmarks of cancer stem cell metabolism Patricia Sancho, David Barneda and Christopher Heeschen Br J Cancer 2016 114: 1305-1312; advance online publication, May 24, 2016; 10.1038/bjc.2016.152 Abstract | Full Text Clinical Studies Top Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data Michael J Sorich, Andrew Rowland, Ganessan Kichenadasse, Richard J Woodman and Arduino A Mangoni Br J Cancer 2016 114: 1313-1317; advance online publication, May 26, 2016; 10.1038/bjc.2016.147 Abstract | Full Text Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial Yoshitomo Yanagimoto, Shuji Takiguchi, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Hiroshi Miyata, Kiyokazu Nakajima, Hiroshi Hosoda, Kenji Kangawa, Masaki Mori and Yuichiro Doki Br J Cancer 2016 114: 1318-1325; advance online publication, June 2, 2016; 10.1038/bjc.2016.160 Abstract | Full Text A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer Xiang Wang, Lin Zhao, Hongfeng Liu, Dingrong Zhong, Wei Liu, Guangliang Shan, Fen Dong, Weisheng Gao, Chunmei Bai and Xiaoyi Li Br J Cancer 2016 114: 1326-1333; advance online publication, May 12, 2016; 10.1038/bjc.2016.126 Abstract | Full Text Clinical impact and network of determinants of tumour necrosis in colorectal cancer Sara A Väyrynen, Juha P Väyrynen, Kai Klintrup, Jyrki Mäkelä, Tuomo J Karttunen, Anne Tuomisto and Markus J Mäkinen Br J Cancer 2016 114: 1334-1342; advance online publication, May 19, 2016; 10.1038/bjc.2016.128 Abstract | Full Text Translational Therapeutics Top CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition Neeraj Kapur, Hina Mir, Clarence E Clark III, Uma Krishnamurti, Derrick J Beech, James W Lillard and Shailesh Singh Br J Cancer 2016 114: 1343-1351; advance online publication, May 5, 2016; 10.1038/bjc.2016.113 Abstract | Full Text Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer Michael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, Ganiraju Manyam, Veerabahdran Baladandayuthapani, Wei Wei, Van K Morris, Michael J Overman, Dipen M Maru, Zhi-Qin Jiang, Stanley R Hamilton and Scott Kopetz Br J Cancer 2016 114: 1352-1361; advance online publication, June 7, 2016; 10.1038/bjc.2016.87 Abstract | Full Text Molecular Diagnostics Top A circulating miRNA assay as a first-line test for prostate cancer screening Evgeniya Sharova, Angela Grassi, Anna Marcer, Katia Ruggero, Francesco Pinto, Pierfrancesco Bassi, Paola Zanovello, Filiberto Zattoni, Donna M D'Agostino, Massimo Iafrate and Vincenzo Ciminale Br J Cancer 2016 114: 1362-1366; advance online publication, May 26, 2016; 10.1038/bjc.2016.151 Abstract | Full Text Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer J S Ankeny, C M Court, S Hou, Q Li, M Song, D Wu, J F Chen, T Lee, M Lin, S Sho, M M Rochefort, M D Girgis, J Yao, Z A Wainberg, V R Muthusamy, R R Watson, T R Donahue, O J Hines, H A Reber, T G Graeber, H R Tseng and J S Tomlinson Br J Cancer 2016 114: 1367-1375; 10.1038/bjc.2016.121 Abstract | Full Text Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation Seema Chugh, Jane Meza, Yuri M Sheinin, Moorthy P Ponnusamy and Surinder K Batra Br J Cancer 2016 114: 1376-1386; advance online publication, May 17, 2016; 10.1038/bjc.2016.116 Abstract | Full Text Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection Wulfran Cacheux, Etienne Rouleau, Adrien Briaux, Petros Tsantoulis, Pascale Mariani, Marion Richard-Molard, Bruno Buecher, Virginie Dangles-Marie, Sophie Richon, Julien Lazartigues, Emmanuelle Jeannot, Fereshteh Farkhondeh, Xavier Sastre-Garau, Anne de La Rochefordière, Alain Labib, Marie-Christine Falcou, Denise Stevens, Arnaud Roth, Sergio Roman-Roman, Emmanuel Mitry, Ivan Bièche and Astrid Lièvre Br J Cancer 2016 114: 1387-1394; advance online publication, May 24, 2016; 10.1038/bjc.2016.144 Abstract | Full Text Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer Didier Meseure, Sophie Vacher, François Lallemand, Kinan Drak Alsibai, Rana Hatem, Walid Chemlali, Andre Nicolas, Leanne De Koning, Eric Pasmant, Celine Callens, Rosette Lidereau, Antonin Morillon and Ivan Bieche Br J Cancer 2016 114: 1395-1404; advance online publication, May 12, 2016; 10.1038/bjc.2016.123 Abstract | Full Text Genetics and Genomics Top MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas Kati Kämpjärvi, Netta Mäkinen, Miika Mehine, Salla Välipakka, Outi Uimari, Esa Pitkänen, Hanna-Riikka Heinonen, Tuomas Heikkinen, Jaana Tolvanen, Anne Ahtikoski, Norma Frizzell, Nanna Sarvilinna, Jari Sjöberg, Ralf Bützow, Lauri A Aaltonen and Pia Vahteristo Br J Cancer 2016 114: 1405-1411; advance online publication, May 17, 2016; 10.1038/bjc.2016.130 Abstract | Full Text Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer Chen Wang, Boris J Winterhoff, Kimberly R Kalli, Matthew S Block, Sebastian M Armasu, Melissa C Larson, Hsiao-Wang Chen, Gary L Keeney, Lynn C Hartmann, Viji Shridhar, Gottfried E Konecny, Ellen L Goode and Brooke L Fridley Br J Cancer 2016 114: 1412-1420; advance online publication, June 2, 2016; 10.1038/bjc.2016.124 Abstract | Full Text Index Top Referee Acknowledgement for 2015 Br J Cancer 2016 114: 1421-1426; 10.1038/bjc.2016.163 Full Text Errata Top Decomposition of spontaneous fluctuations in tumour oxygenation using BOLD MRI and independent component analysis Miguel R Gonçalves, S Peter Johnson, Rajiv Ramasawmy, R Barbara Pedley, Mark F Lythgoe and Simon Walker-Samuel Br J Cancer 2016 114: e13; advance online publication, May 26, 2016; 10.1038/bjc.2016.140 Full Text Enthusiasm for cancer screening in Great Britain: a general population survey J Waller, K Osborne and J Wardle Br J Cancer 2016 114: e14; advance online publication, May 26, 2016; 10.1038/bjc.2016.138 Full Text Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas D C Rowlands, M Ito, D C Mangham, G Reynolds, H Herbst, M T Hallissey, J W L Fielding, K M Newbold, E L Jones, L S Young and G Niedobitek Br J Cancer 2016 114: e15; advance online publication, May 26, 2016; 10.1038/bjc.2016.156 Full Text Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years K Coffey, V Beral, J Green, G Reeves and I Barnes on behalf of the Million Women Study Collaborators Br J Cancer 2016 114: e16; advance online publication, May 26, 2016; 10.1038/bjc.2016.13 Full Text Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis Robert S Phillips, Lillian Sung, Roland A Ammann, Richard D Riley, Elio Castagnola, Gabrielle M Haeusler, Robert Klaassen, Wim JE Tissing, Thomas Lehrnbecher, Julia Chisholm, Hana Hakim, Neil Ranasinghe, Marianne Paesmans, Ian M Hann and Lesley A Stewart on behalf of the PICNICC Collaboration Br J Cancer 2016 114: e17; advance online publication, May 26, 2016; 10.1038/bjc.2016.137 Full Text Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas G H Bain, E Collie-Duguid, G I Murray, F J Gilbert, A Denison, F Mckiddie, T Ahearn, I Fleming, J Leeds, P Phull, K Park, S Nanthakumaran, K M Matula, H I Grabsch, P Tan, A Welch, L Schweiger, A Dahle-Smith, G Urquhart, M Finegan and R D Petty Br J Cancer 2016 114: e18; advance online publication, May 26, 2016; 10.1038/bjc.2016.139 Full Text Corrigenda Top Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc E Roccato, C Miranda, V Ranzi, M Gishizki, M A Pierotti and A Greco Br J Cancer 2016 114: e19; advance online publication, May 26, 2016; 10.1038/bjc.2016.131 Full Text Has the survival of patients with glioblastoma changed over the years? R M deSouza, H Shaweis, C Han, V Sivasubramaniam, L Brazil, R Beaney, G Sadler, S Al-Sarraj, T Hampton, J Logan, V Hurwitz, R Bhangoo, R Gullan and K Ashkan Br J Cancer 2016 114: e20; advance online publication, May 26, 2016; 10.1038/bjc.2016.134 Full Text Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer Yvette Drew, Jonathan Ledermann, Geoff Hall, Daniel Rea, Ros Glasspool, Martin Highley, Gordon Jayson, Julieann Sludden, James Murray, David Jamieson, Sarah Halford, Gary Acton, Zoe Backholer, Raffaella Mangano, Alan Boddy, Nicola Curtin and Ruth Plummer Br J Cancer 2016 114: e21; advance online publication, May 26, 2016; 10.1038/bjc.2016.133 Full Text Polygenic susceptibility to testicular cancer: implications for personalised health care Kevin Litchfield, Jonathan S Mitchell, Janet Shipley, Robert Huddart, Ewa Rajpert-De Meyts, Niels E Skakkebæk, Richard S Houlston and Clare Turnbull Br J Cancer 2016 114: e22; advance online publication, May 26, 2016; 10.1038/bjc.2016.136 Full Text Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time Jennifer C Melvin, Arnie D Purushotham, Hans Garmo, Sarah E Pinder, Ian S Fentiman, Cheryl Gillett, Anca Mera, Margreet Lüchtenborg, Lars Holmberg and Mieke Van Hemelrijck Br J Cancer 2016 114: e23; advance online publication, May 26, 2016; 10.1038/bjc.2016.135 Full Text Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder S Hafeez, A Horwich, O Omar, K Mohammed, A Thompson, P Kumar, V Khoo, N Van As, R Eeles, D Dearnaley and R Huddart Br J Cancer 2016 114: e24; advance online publication, May 26, 2016; 10.1038/bjc.2016.132 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.